Superinfection and recombination of infectious laryngotracheitis virus vaccines in the natural host

Fakhri, Omid; Devlin, Joanne M.; Browning, Glenn F.; Coppo, Mauricio J. C.; Quinteros, Jose A.; Diaz-Mendez, Andres; Lee, Sang-Won; Hartley, Carol A.

Abstract

Infectious laryngotracheitis virus (ILTV, Gallid alphaherpesvirus 1) causes severe respiratory disease in chickens and has a major impact on the poultry industry worldwide. Live attenuated vaccines are widely available and are administered early in the life of commercial birds, often followed by one or more rounds of revaccination, generating conditions that can favour recombination between vaccines. Better understanding of the factors that contribute to the generation of recombinant ILTVs will inform the safer use of live attenuated herpesvirus vaccines. This study aimed to examine the parameters of infection that allow superinfection and may enable the generation of recombinant progeny in the natural host. In this study, 120 specific-pathogen free (SPF) chickens in 8 groups were inoculated with two genetically distinct live-attenuated ILTV vaccine strains with 1-4 days interval between the first and second vaccinations. After inoculation, viral genomes were detected in tracheal swabs in all groups, with lowest copies detected in swabs collected from the groups where the interval between inoculations was 4 days. Superinfection of the host was defined as the detection of the virus that was inoculated last, and this was detected in tracheal swabs from all groups. Virus could be isolated from swabs at a limited number of timepoints, and these further illustrated superinfection of the birds as recombinant viruses were detected among the progeny. This study has demonstrated superinfection at host level and shows recombination events occur under a very broad range of infection conditions. The occurrence of superinfection after unsynchronised infection with multiple viruses, and subsequent genomic recombination, highlight the importance of using only one type of vaccine per flock as the most effective way to limit recombination. (C) 2020 The Authors. Published by Elsevier Ltd.

Más información

Título según WOS: ID WOS:000582634300016 Not found in local WOS DB
Título de la Revista: VACCINE
Volumen: 38
Número: 47
Editorial: ELSEVIER SCI LTD
Fecha de publicación: 2020
Página de inicio: 7508
Página final: 7516
DOI:

10.1016/j.vaccine.2020.09.064

Notas: ISI